pharma · Hepatocellular Carcinoma · Hepatocellular Carcinoma (HCC) · TPST
Tempest Therapeutics
Tempest Therapeutics clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Brisbane, USA HQ
14 Employees
Public company Type
TPST · NYSE Ticker
Company details
- Status
- Public
- HQ
- Brisbane, USA
- Employees
- 14
- Programs
- 3
- Drugs
- 1
- Patents
- 10
Tempest Therapeutics projects
1 ClinicalTrials.gov programs sponsored by Tempest Therapeutics.
Tempest Therapeutics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Tempest Therapeutics have?
1 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.